| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/31/2013 | CN102028703B New application of inulin |
| 07/31/2013 | CN101980710B Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments |
| 07/31/2013 | CN101821260B Substituted oxazolidinone derivatives |
| 07/31/2013 | CN101663293B Quinoline-carboxamide derivatives as p2y12 antagonists |
| 07/31/2013 | CN101496917B Serum preparation equipment for cell culture as well as serum preparation method and cell culture method |
| 07/30/2013 | CA2586053C Platelets from stem cells |
| 07/30/2013 | CA2460575C Enzymatic conversion of blood group a, b, and ab red blood cells using .alpha.-n-acetylgalactosaminidases and .alpha.-galactosidases with unique substrate specificities and kinetic properties |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/25/2013 | WO2013109365A1 Vasoconstrictor for use in the treatment of abnormal uterine bleeding and apparatus for delivery thereof |
| 07/25/2013 | WO2013108822A1 Des(rhamnosyl) acteoside-containing olive extract |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | CA2861350A1 Organic compounds |
| 07/24/2013 | EP2617737A1 High purity heparin and production method therefor |
| 07/24/2013 | EP2616480A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 07/24/2013 | CN103221061A Factor II and fibrinogen for treatment of haemostatic disorders |
| 07/24/2013 | CN103215234A Adenovirus with zinc finger nuclease expression element and donor DNA, and construction method and application |
| 07/24/2013 | CN103214591A 2,5-anhydrated talose or derivatives thereof terminal low-molecular-weight glycosaminoglycan derivative |
| 07/24/2013 | CN103214555A Peptide inhibitors for mediating stress responses |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN103212057A Medical composition containing low-dosage desmopressin |
| 07/24/2013 | CN103211979A New use of dendrobium officinale kimura et migo in diabetic complication prevention and treatment |
| 07/24/2013 | CN103211978A Chinese medicine composition for treating kidney-yang deficiency type aplastic anemia |
| 07/24/2013 | CN103211952A Traditional Chinese medicine composition used for treating edema |
| 07/24/2013 | CN103211907A Siwu decoction formulated particles, and preparation method and detection method thereof |
| 07/24/2013 | CN103211861A Special-traditional Chinese medicine thrombolytic injection medicament efficacy |
| 07/24/2013 | CN103211809A Application of terpenoid |
| 07/24/2013 | CN103211774A Gabexate mesylate composition for injection and preparation method thereof |
| 07/24/2013 | CN103211766A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/24/2013 | CN103211759A Puerarin nanocrystalline medical composition and preparation method thereof |
| 07/24/2013 | CN102755366B Honeysuckle soft capsule containing chlorogenic acid compound |
| 07/24/2013 | CN102477069B Pro-Ala-Lys-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesizing method thereof, and application thereof as thrombolytic agent |
| 07/24/2013 | CN102477068B Amino acid derivative for preparing thrombus dissolving medicament, and preparation method and application thereof |
| 07/24/2013 | CN102430064B Composition for tonifying primordial qi and removing meridian obstruction and regulating blood and preparation method thereof |
| 07/24/2013 | CN102357195B Medicinal composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
| 07/24/2013 | CN102327368B Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 07/24/2013 | CN102058898B Powder with antibacterial and haemostatic effects and preparation method and applications thereof |
| 07/24/2013 | CN101862333B Stable sodium levofolinate oral preparation and preparation method thereof |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492363 Use of difructose anhydride-containing composition |
| 07/23/2013 | US8492352 Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain |
| 07/23/2013 | US8491872 Cinnamic acid-based oligomers and uses thereof |
| 07/23/2013 | CA2607018C Indwelling heat exchange catheter and method of using same |
| 07/23/2013 | CA2606716C Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis |
| 07/23/2013 | CA2544574C Stable vitamin b6 derivative |
| 07/23/2013 | CA2514646C Factor viii polypeptide |
| 07/23/2013 | CA2432644C Pharmaceutical composition comprising aspirintm and cs-747 |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/18/2013 | WO2013105665A1 Collagen structure, and method for producing collagen structure |
| 07/18/2013 | WO2013082282A8 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease. |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013070116A3 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants) |
| 07/18/2013 | WO2013025918A3 Methods useful in the prevention of hypoxic injury |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130184216 Novel albumin-free factor viii formulations |
| 07/17/2013 | EP2615165A1 Culture method related to differentiation of pluripotent stem cells into blood cells |
| 07/17/2013 | EP2613783A1 Methods for the treatment or prophylaxis of thrombosis or embolism |
| 07/17/2013 | CN103209997A High purity heparin and production method therefor |
| 07/17/2013 | CN103205411A Small-molecular-weight sipunculus nudus fibrinolysin and preparation method and applications thereof |
| 07/17/2013 | CN103205410A Recombinant microplasmin, its preparation method and application |
| 07/17/2013 | CN103204850A Acetylsalicylic acid berberine salt, preparation method and application thereof |
| 07/17/2013 | CN103204816A Piperazinyl pyrimidine derivative, and preparation method and application thereof |
| 07/17/2013 | CN103203019A Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders |
| 07/17/2013 | CN103203014A Preparation method of blended functional surgical irrigating fluid |
| 07/17/2013 | CN103203013A Methods And Compositions For Oxygen Transport Comprising A High Oyzgen Affinity |
| 07/17/2013 | CN103202999A Modified peach pit flatus-smoothing oral liquid used for operative complications and preparation method thereof |
| 07/17/2013 | CN103202817A Preparation method for mannitol grains capable of being directly pressed |
| 07/17/2013 | CN102743729B Oral hemostasis soup for treating gynaecologic haemorrhagia and preparation method thereof |
| 07/17/2013 | CN102614442B Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis |
| 07/17/2013 | CN102429865B Preparation method of super-micro molecular iron dextran |
| 07/17/2013 | CN102423368B Chinese medicinal composition for treating sequelae of cerebral thrombosis and cerebral hemorrhage, as well as preparation method thereof |
| 07/17/2013 | CN102379887B Cardiovascular disease treating medicament and preparation method and application thereof |
| 07/17/2013 | CN102274267B Preparation method of vacuum packaged pseudostellaria roots |
| 07/17/2013 | CN102210656B Medicinal composition containing carbazochrome sodium sulfonate compound and preparation method thereof |
| 07/17/2013 | CN102206276B Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| 07/17/2013 | CN102144974B Liposome preparation for anticoagulant thrombolytic difunctional fusion protein and preparation method thereof |
| 07/17/2013 | CN102002052B Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 07/17/2013 | CN101932577B Heteroaryl-substituted piperidines |
| 07/17/2013 | CN101824455B Soy protein oligopeptide, and preparation method and use thereof |
| 07/17/2013 | CN101374815B Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 07/17/2013 | CN101006063B Five-membered heterocycles useful as serine protease inhibitors. |
| 07/16/2013 | US8487081 Antibodies specific for human hepcidin |
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8487000 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 07/16/2013 | US8486892 Blood coagulation factor inhibitors |
| 07/16/2013 | US8486464 Herbal composition for angina pectoris, method to prepare same and uses thereof |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | CA2741575C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/16/2013 | CA2741412C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/16/2013 | CA2591786C Prevention of thrombus formation and/or stabilization |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/11/2013 | WO2013103981A1 Compositions and methods of use of fndc5 polypeptides |
| 07/11/2013 | WO2013103567A2 Methods of blocking platelet activation during extracorporeal circulation using cangrelor |
| 07/11/2013 | US20130177597 Mango seed herbal medication |